BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  Rockley Photonics Announces Bioptx™ Biomarker Sensing Platform for Professional Healthcare, Including First-of-its-Kind Non-Invasive, Continuous Biosensing Wristband

  Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced the Bioptx™ platform of biomarker sensing products and solutions for the medical and healthcare market.

  February 8, 2022

   · 

  11 min read
• Business

  n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases

  n-Lorem, a nonprofit foundation , is collaborating with Cytiva in support of n-Lorem’s effort to discover and provide experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients.

  February 8, 2022

   · 

  3 min read
• Business

  MaaT Pharma and Skyepharma Have Entered a Partnership to Establish the First Exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France

  MaaT Pharma (EURONEXT: MAAT - the “Company”), and Skyepharma, today announced they have entered a partnership agreement to build, to date, France’s largest specialized cGMP manufacturing facility for ecosystem microbiome-based therapeutics.

  February 8, 2022

   · 

  6 min read
• BioForest

  SEngine Precision Medicine and Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment for Aggressive and Untreatable Tumors

  SEngine Precision Medicine Inc. and Oncodesign have announced the signature of a research collaboration agreement for R&D of a new personalized cancer treatment for aggressive and untreatable tumors.

  February 8, 2022

   · 

  8 min read
• Cell-Free DNA (cfDNA) Testing Market Size to Reach USD 28.28 Billion in 2028 | Industry Trends – Increasing Prevalence of Chromosomal Disorders and Rising Number of Cell-Free DNA (Cfdna) Testing Procedures

  According to Emergen Research, the global cell-free DNA (cfDNA) testing market size was USD 4.79 billion in 2020 and is expected to reach USD 28.28 billion in 2028 and register a revenue CAGR of 26.2% during the forecast period, 2021-2028.

  February 8, 2022

   · 

  7 min read
• Travelers Vaccines Market Research Report 2021 – Industry Trends and Demand

  The industry analysis report is considered a valuable source of information about the global Travelers Vaccines industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

  February 8, 2022

   · 

  7 min read
• Deals

  Comar Expands Internationally with Acquisition of European Medical and Pharmaceutical Injection Molder - Automatic Plastics Ltd.

  Comar, a premier supplier of custom medical devices & assemblies and specialty packaging solutions, announced today it has acquired Automatic Plastics Ltd., a contract manufacturer of injection molded products primarily for the medical device and pharmaceutical sectors.

  February 8, 2022

   · 

  4 min read
• Genetown

  ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases

  ERYTECH Pharma announced the allowance of a US patent application covering arginine deiminase encapsulated into red blood cells for the treatment of arginase-1 deficiency, a debilitating rare metabolic disease.

  February 8, 2022

   · 

  7 min read
• Business

  Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call

  Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2021 financial results and provide a corporate update on February 15, 2022.

  February 8, 2022

   · 

  1 min read
• Business

  Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022

  Anika Therapeutics, Inc. announced that the Company plans to issue its fourth quarter and year-end 2021 financial results after the close of the market on Tuesday, March 8, 2022 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

  February 8, 2022

   · 

  1 min read